Weijing Wu

Kingmed Diagnostics

Papers

1

Total Citations

3

H-Index

1

About

Weijing Wu is a pioneering thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer treatment, particularly through the development and evaluation of single-port robotic-assisted approaches. Her most notable contribution is the landmark study "Safety and Feasibility of Novel Single-Port Robotic-Assisted Lobectomy/Segmentectomy for Lung Cancer" (2025), which has already garnered 3 citations—a strong early indicator of its impact in the field. This work demonstrates the viability of a cutting-edge surgical platform that reduces trauma and improves recovery times for patients, positioning Wu at the forefront of robotic thoracic surgery. Her research bridges engineering innovation with clinical application, addressing critical gaps in surgical oncology. As a rising voice in the field, Wu’s achievements underscore her commitment to refining surgical precision and patient outcomes, making her a key figure to watch in the evolution of lung cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Safety and Feasibility of Novel Single-Port Robotic-Assisted Lobectomy/Segmentectomy for Lung Cancer
3 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Kingmed Diagnostics

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago